NYU Langone Medical Center Receives Two Grants From the Avon Foundation for Women

$2.375M in Grants Will Support Breast Cancer Research in Premenopausal Women and Help Improve Accessibility to Treatment for Underserved Women with Breast Cancer

May 13, 2011 (All day)

NYU Langone Medical Center today announced it received two high impact grants totaling $2.375 million from the Avon Foundation for Women. One grant will support novel research analyzing pregnancy-related gene patterns in cells from the breasts of premenopausal women. The second grant will support an integrated care program for breast cancer patients from underserved communities at the NYU Cancer Institute, an NCI-designated cancer center, and Bellevue Hospital Center.

“These grants from the Avon Foundation for Women will help support important research and clinical care in the area of breast cancer at the medical center,” said William L Carroll, MD, the Julie and Edward J. Minskoff Professor of Pediatrics, Departments of Pediatrics and Pathology, Division of Oncology, and director, NYU Cancer Institute. “Understanding the genetic basis of cancer is a critical component of ultimately identifying ways to treat – and ultimately eradicate – the disease. And, it is equally important that as treatments become available, all women, regardless of socioeconomic status or literacy levels understand and have access to all of the treatments available to them.”

More specifically, a $2.1 million grant will support a research program – “Characterization and Validation of Genomic Expression Signature of Pregnancy, Phase 2” – led by Paolo G. Toniolo, MD, professor, Departments of Obstetrics and Gynecology and Environmental Medicine, and director, Division of Epidemiology. The study will focus on characterizing pregnancy-related genomic expression signature in the breasts of woman who are premenopausal.

A second $275K grant supports a patient navigation and survivorship program targeted to primarily underserved Latina and Chinese breast cancer patients under the leadership of Robert J. Schneider, PhD, the Albert B. Sabin Professor of Microbiology and Molecular Pathogenesis, Departments of Microbiology and Radiation Oncology. The program is designed to improve communications between patients and their providers and help foster informed surgical decision-making among patients with low literacy.  In addition, it will facilitate access to clinical trials for patients from these populations and track survivors to help ensure they receive the appropriate follow-up care.

 

Media Inquiries:
Christopher Rucas

212-404-3525 | christopher.rucas@nyumc.org

Deborah (DJ) Sabalusky

212-404-3567 | deborah.sabalusky@nyumc.org